BioSpectrum announces the hits and misses of 2013

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...

January 2, 2014 | Thursday | Analysis
ShangPharma enters consolidation mode

Singapore: ShangPharma entered into a definitive agreement and plan of merger with ShangPharma Holdings, ShangPharma Pa...

December 24, 2012 | Monday | News
WuXi Life Science to acquire WuXi PharmaTech for around $3.3 bn

Singapore: WuXi PharmaTech, research and technology platform company serving the pharmaceutical, biotechnology, and medi...

August 17, 2015 | Monday | Company results
China's IMPACT Therapeutics raises $10mn

Singapore: IMPACT Therapeutics, a company dedicated to the discovery, development and commercialization of novel and "be...

February 24, 2016 | Wednesday | News
China's online medicine sales crosses $1 trillion

Singapore: According to a report issued by Chinese drug authority, online sales of medicines are skyrocketing in China w...

July 9, 2015 | Thursday | News
Bayer, Regeneron start phase III trial of Eylea

Singapore: Regeneron Pharmaceuticals and Bayer HealthCare have initiated a new phase III trial (named Vivid East-DME) t...

February 20, 2013 | Wednesday | News
PerkinElmer launches genetic disorder screening system in China

Singapore: PerkinElmer, has announced that it has received market authorization from the China Food and Drug Administrat...

April 17, 2015 | Friday | News
CFDA approves the use of 3D printed hip implants

Singapore: The Chinese Food and Drug Administration has approved the use of 3D printed hip implants in China, a breakthr...

September 2, 2015 | Wednesday | News
Gilead Science, WuXi partner to accelerate drug development

Singapore: Gilead Sciences and WuXi PharmaTech have entered into a strategic partnership to conduct analytical and stabi...

October 30, 2015 | Friday | News
OxOnc, Pfizer drug trial to be held in Asia

Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...

February 11, 2013 | Monday | News
China: Shines despite slower pace of growth

The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the coun...

May 14, 2013 | Tuesday | Analysis
World's largest pharma event opens in Shanghai

Singapore: Literally all the roads led to the swanky National Exhibition and Convention Center (NECC), Shanghai as over...

May 15, 2015 | Friday | News
Boehringer, Lilly diabetes drug shows +ve results

Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...

June 25, 2013 | Tuesday | News
Moleac takes Traditional Chinese Medicine to the world

With an intention to address a therapeutic gap by introducing novel drug in the market, a group comprising Mr David Pica...

April 12, 2012 | Thursday | News
Oncology drug pipeline is the most robust'

Singapore: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with...

August 6, 2015 | Thursday | Analysis
Swiss firm partners with Mundipharma to expand in Asia

Singapore: Helsinn, a Swiss pharmaceutical firm focused on cancer care, has partnered with Singapore based pain drug com...

April 3, 2015 | Friday | News
PPD opens central lab in Shanghai

Singapore: Pharmaceutical Product Development (PPD) has opened a central laboratory in Shanghai, China, to deliver globa...

April 21, 2015 | Tuesday | News
Fosun Pharma, WuXi to acquire US biotech firm Ambrx

Singapore: A consortium consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, Ch...

May 28, 2015 | Thursday | News